Literature DB >> 24756990

Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue.

Silvia Piconese1, Eleonora Timperi, Ilenia Pacella, Valeria Schinzari, Claudio Tripodo, Massimo Rossi, Nicola Guglielmo, Gianluca Mennini, Gian Luca Grazi, Simona Di Filippo, Stefania Brozzetti, Katia Fazzi, Guido Antonelli, Maria Antonietta Lozzi, Massimo Sanchez, Vincenzo Barnaba.   

Abstract

UNLABELLED: Regulatory T cells (Tregs) can be considered as a mixed population of distinct subsets, endowed with a diverse extent and quality of adaptation to microenvironmental signals. Here, we uncovered an opposite distribution of Treg expansion, phenotype, and plasticity in different microenvironments in the same organ (liver) derived from patients with chronic hepatitis C: On the one side, cirrhotic and tumor fragments were moderately and highly infiltrated by Tregs, respectively, expressing OX40 and a T-bethigh IFN-γ- "T-helper (Th)1-suppressing" phenotype; on the other side, noncirrhotic liver specimens contained low frequencies of Tregs that expressed low levels of OX40 and highly produced interferon-gamma (IFN-γ; T-bet+IFN-γ+), thus becoming "Th1-like" cells. OX40-expressing and Th1-suppressing Tregs were enriched in the Helios-positive subset, carrying highly demethylated Treg cell-specific demethylated region that configures committed Tregs stably expressing forkhead box protein 3. OX40 ligand, mostly expressed by M2-like monocytes and macrophages, boosted OX40+ Treg proliferation and antagonized the differentiation of Th1-like Tregs. However, this signal is counteracted in noncirrhotic liver tissue (showing various levels of inflammation) by high availability of interleukin-12 and IFN-γ, ultimately leading to complete, full Th1-like Treg differentiation.
CONCLUSION: Our data demonstrate that Tregs can finely adapt, or even subvert, their classical inhibitory machinery in distinct microenvironments within the same organ.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756990     DOI: 10.1002/hep.27188

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  31 in total

Review 1.  Strategies for combining immunotherapy with radiation for anticancer therapy.

Authors:  Steven N Seyedin; Jonathan E Schoenhals; Dean A Lee; Maria A Cortez; Xiaohong Wang; Sharareh Niknam; Chad Tang; David S Hong; Aung Naing; Padmanee Sharma; James P Allison; Joe Y Chang; Daniel R Gomez; John V Heymach; Ritsuko U Komaki; Laurence J Cooper; James W Welsh
Journal:  Immunotherapy       Date:  2015-08-27       Impact factor: 4.196

2.  Regulation of immunopathology in hepatitis B virus infection.

Authors:  Silvia Piconese; Vincenzo Barnaba
Journal:  Nat Med       Date:  2015-06       Impact factor: 53.440

3.  IRF8: identity-keeper for suppressive Th1-like Treg cells.

Authors:  Gap Ryol Lee
Journal:  Cell Mol Immunol       Date:  2018-05-22       Impact factor: 11.530

Review 4.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

5.  Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer.

Authors:  Eleonora Timperi; Ilenia Pacella; Valeria Schinzari; Chiara Focaccetti; Luca Sacco; Francesco Farelli; Roberto Caronna; Gabriella Del Bene; Flavia Longo; Antonio Ciardi; Sergio Morelli; Anna Rita Vestri; Piero Chirletti; Vincenzo Barnaba; Silvia Piconese
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

6.  OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis.

Authors:  Kunlin Xie; Lin Xu; Hao Wu; Haotian Liao; Lin Luo; Mingheng Liao; Jianping Gong; Yang Deng; Kefei Yuan; Hong Wu; Yong Zeng
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

7.  AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.

Authors:  Alexandra Kitz; Marine de Marcken; Anne-Sophie Gautron; Mitja Mitrovic; David A Hafler; Margarita Dominguez-Villar
Journal:  EMBO Rep       Date:  2016-06-16       Impact factor: 8.807

8.  Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth.

Authors:  Ilenia Pacella; Claudio Procaccini; Chiara Focaccetti; Stefano Miacci; Eleonora Timperi; Deriggio Faicchia; Martina Severa; Fabiana Rizzo; Eliana Marina Coccia; Fabrizia Bonacina; Nico Mitro; Giuseppe Danilo Norata; Grazisa Rossetti; Valeria Ranzani; Massimiliano Pagani; Ezio Giorda; Yu Wei; Giuseppe Matarese; Vincenzo Barnaba; Silvia Piconese
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

9.  OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Authors:  Benjamin Weixler; Eleonora Cremonesi; Roberto Sorge; Manuele Giuseppe Muraro; Tarik Delko; Christian A Nebiker; Silvio Däster; Valeria Governa; Francesca Amicarella; Savas D Soysal; Christoph Kettelhack; Urs W von Holzen; Serenella Eppenberger-Castori; Giulio C Spagnoli; Daniel Oertli; Giandomenica Iezzi; Luigi Terracciano; Luigi Tornillo; Giuseppe Sconocchia; Raoul A Droeser
Journal:  Oncotarget       Date:  2015-11-10

10.  'Hardcore' OX40+ immunosuppressive regulatory T cells in hepatic cirrhosis and cancer.

Authors:  Silvia Piconese; Eleonora Timperi; Vincenzo Barnaba
Journal:  Oncoimmunology       Date:  2014-06-17       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.